Ramon Alegret, MD
Pain Medicine · Miami, FLNPI 1336462423
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,872 of the $2,977 with a category attached, or 62.9%. Paratek Pharmaceuticals, Inc. accounts for 93.2% of it on its own, with 7 other manufacturers making up the rest. 2024 is the largest year on record at $2,775, more than ten times the $31 reported in 2019.
Across 20 payments — averaging $148.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$3K
- Pfizer$44
- Trevena, Inc.$40
- Redhill Biopharma Inc.$36
- Forte Bio-pharma LLC$30
- Kowa Pharmaceuticals America, Inc.$20
- plus $31 from 2 others
Across 5 payments — averaging $13,195 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- American Regent$45K
- Bristol Myers Squibb$19K
- GSK$2K
What the payments were for
- Travel & lodging$1,87263%
- Food & beverage$47316%
- Education$171%
- Gifts$43515%
- Entertainment$1796%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 10 | $2,775 |
| Pfizer | 2 | $44 |
| Trevena, Inc. | 2 | $40 |
| Redhill Biopharma Inc. | 2 | $36 |
| Forte Bio-pharma LLC | 1 | $30 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Amgen | 1 | $19 |
| Kaleo, Inc. | 1 | $12 |
How this compares
$2,977 in reported general payments places this provider in the 55th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,621 | $41,682 |
| OxycontinOxycodone Hcl | 13 | $19,604 |
| Diclofenac Sodium | 173 | $18,001 |
| Celecoxib | 92 | $8,881 |
| Naloxone Hcl | 107 | $6,545 |
| Ondansetron Hcl | 12 | $5,890 |
| Pregabalin | 148 | $5,578 |
| Tramadol Hcl | 573 | $5,489 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 225 | $4,926 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 108 | $2,511 |
| Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol | 16 | $2,346 |
| Oxycodone Hcl | 113 | $2,342 |
| Gabapentin | 248 | $1,766 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 48 | $1,074 |
| Cyclobenzaprine Hcl | 118 | $734 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Miami
- Jeffrey GudinMiami$356K
- Ruben SchwartzMiami$19K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Stephen PylesOcala$115K
- Orlando FloreteJacksonville$86K
- Michael GreeneMiddleburg$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.